Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
As a precaution, tirzepatide should be used with caution in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Where coverage does exist, it is frequently accompanied by strict criteria, including body mass index thresholds, documentation of failed lifestyle interventions, and repeated prior authorization processes
How to Manage and Prevent This The good news is that there are practical steps you can take: Work with a supervised program
Novo Nordisk, the company that makes both drugs, says it is currently experiencing "intermittent supply disruptions" of Ozempic due to "incredible demand" paired with supply chain constraints
Retatrutide is an investigational triple receptor agonist that simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
